These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. [Anti-hypertensive therapy in pregnancy-induced hypertension with urapidil]. Wacker J; Müller J; Grischke EM; Unkels R; Bastert G Zentralbl Gynakol; 1994; 116(5):271-3. PubMed ID: 8023622 [TBL] [Abstract][Full Text] [Related]
47. Efficacy of urapidil in the management of essential hypertension: a comparison with captopril. Rosenthal J; Haerlin R J Hypertens Suppl; 1988 Dec; 6(2):S69-71. PubMed ID: 3068344 [TBL] [Abstract][Full Text] [Related]
49. Effects of sodium nitroprusside and urapidil on gas exchange and ventilation: perfusion ratios in patients with congestive heart failure. Adnot S; Radermacher P; Andrivet P; Dubois-Rande JL; Dupeyrat A; Lemaire F Drugs; 1990; 40 Suppl 4():65-6. PubMed ID: 2092972 [No Abstract] [Full Text] [Related]
50. The effect of rapid blood pressure control on P-wave dispersion in hypertensive urgency. Karaca I; Durukan P; Dagli N; Yavuzkir M; Ikizceli I; Balin M Adv Ther; 2008 Dec; 25(12):1303-14. PubMed ID: 19043679 [TBL] [Abstract][Full Text] [Related]
51. Comparison of the effects of nitroglycerin and nitroprusside on transmitral Doppler flow parameters in patients with hypertensive urgency. Eryonucu B; Güler N; Güntekin U; Tuncer M Ann Pharmacother; 2005 Jun; 39(6):997-1001. PubMed ID: 15886286 [TBL] [Abstract][Full Text] [Related]
52. Pharmacological interventions for hypertension in children. Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305 [TBL] [Abstract][Full Text] [Related]
53. Randomized, prospective trial of fenoldopam vs sodium nitroprusside in the treatment of acute severe hypertension. Fenoldopam Study Group. Panacek EA; Bednarczyk EM; Dunbar LM; Foulke GE; Holcslaw TL Acad Emerg Med; 1995 Nov; 2(11):959-65. PubMed ID: 8536121 [TBL] [Abstract][Full Text] [Related]
54. [Therapy of the hypertensive crisis with urapidil. Various effects on patients with or without coronary disease]. Zähringer J; Klepzig M; Greif J; Ludwig B; Strauer B Fortschr Med; 1984 Jun; 102(22):624-8. PubMed ID: 6469170 [TBL] [Abstract][Full Text] [Related]
55. Pharmacodynamics and pharmacokinetics of urapidil in hypertensive patients: a crossover study comparing infusion with an infusion-capsule combination. Kirsten R; Nelson K; Molz KH; Haerlin R; Steinijans VW Eur J Clin Pharmacol; 1987; 32(1):61-5. PubMed ID: 3582469 [TBL] [Abstract][Full Text] [Related]
57. Hypertensive crisis in children. Groshong T Pediatr Ann; 1996 Jul; 25(7):368-71, 375-6. PubMed ID: 8827760 [TBL] [Abstract][Full Text] [Related]
58. The effect of urapidil on responses to phenylephrine, angiotensin and isoprenaline in man. Tomlinson B; Renondin JC; Graham BR; Prichard BN Eur J Clin Pharmacol; 1991; 41(1):1-3. PubMed ID: 1685992 [TBL] [Abstract][Full Text] [Related]
59. [Renal and adrenal function following acute administration of urapidil in hypertensive patients with normal and impaired renal function]. Wambach G; Godehardt E; Lang R; Haerlin R; Meurer KA Arzneimittelforschung; 1987 Aug; 37(8):960-4. PubMed ID: 3675693 [TBL] [Abstract][Full Text] [Related]
60. Overview of clinical trials with urapidil. Schook CE; Radtke H; Wurst W; Thieme G Am J Cardiol; 1989 Aug; 64(7):30D-37D. PubMed ID: 2667312 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]